We found that THL could inhibit the phosphorylation of ERK1/2 but not that of AKT (Fig 2D) in CT-26 cancer cells, indicating that THL can inhibit the ERK signaling pathway but not the phosphatidylinositol-3-OH kinase (PI3K)/AKT signaling pathway. The gene discussed is MAPK3; the disease is cancer.